Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2008/320150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562460445376512 |
|---|---|
| author | Curtis L Cooper Robert J Bailey Vince G Bain Frank Anderson Eric M Yoshida Mel Krajden Paul Marotta for the Canadian Pegasys Study Group |
| author_facet | Curtis L Cooper Robert J Bailey Vince G Bain Frank Anderson Eric M Yoshida Mel Krajden Paul Marotta for the Canadian Pegasys Study Group |
| author_sort | Curtis L Cooper |
| collection | DOAJ |
| description | BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations. |
| format | Article |
| id | doaj-art-36c5a9bb10b1431f9caa1aaedc331f0f |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-36c5a9bb10b1431f9caa1aaedc331f0f2025-02-03T01:22:35ZengWileyCanadian Journal of Gastroenterology0835-79002008-01-0122867768010.1155/2008/320150Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal CanadiansCurtis L Cooper0Robert J Bailey1Vince G Bain2Frank Anderson3Eric M Yoshida4Mel Krajden5Paul Marotta6for the Canadian Pegasys Study GroupUniversity of Ottawa, Ottawa, Ontario, CanadaRoyal Alexandra Hospital, CanadaUniversity of Alberta, Edmonton, Alberta, CanadaThe Liver and Intestinal Research Centre, CanadaVancouver Hospital Health Sciences Centre, CanadaBC Centre for Disease Control, Vancouver, British Columbia, CanadaUniversity of Western Ontario, London, Ontario, CanadaBACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.http://dx.doi.org/10.1155/2008/320150 |
| spellingShingle | Curtis L Cooper Robert J Bailey Vince G Bain Frank Anderson Eric M Yoshida Mel Krajden Paul Marotta for the Canadian Pegasys Study Group Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians Canadian Journal of Gastroenterology |
| title | Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians |
| title_full | Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians |
| title_fullStr | Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians |
| title_full_unstemmed | Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians |
| title_short | Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians |
| title_sort | outcomes of peginterferon alpha 2a and ribavirin hepatitis c therapy in aboriginal canadians |
| url | http://dx.doi.org/10.1155/2008/320150 |
| work_keys_str_mv | AT curtislcooper outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians AT robertjbailey outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians AT vincegbain outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians AT frankanderson outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians AT ericmyoshida outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians AT melkrajden outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians AT paulmarotta outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians AT forthecanadianpegasysstudygroup outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians |